There are several markers for evaluation of DKD; Kidney injury molecule 1 (KIM-1) and Neutrophil gelatinase-associated lipocalin (NGAL) are among the new markers, which based on the Food and Drug Administration (FDA) reports might be appropriate for kidney injury evaluation (9, 10). Here, HAVCR1 is linked to diabetic kidney disease.